TANG CAPITAL MANAGEMENT LLC

CIK: 0001232621Latest portfolio: $2.0B · Q4 2025

Holdings

75

Total Value

$2.0B

New Positions

8

Closed Positions

127

#StockSharesValue% PortfolioChangeType
1
AUPHAURINIA PHARMACEUTICALS INC
11,329,500$180.7M8.93%
2
GLPGGALAPAGOS NV
3,921,219$128.2M6.33%-229,975
3
PTCTPTC THERAPEUTICS INC
1,500,000$113.9M5.63%
4
CELCCELCUITY INC
1,050,000$104.7M5.17%-100,000
5
MIRMMIRUM PHARMACEUTICALS INC
1,236,027$97.6M4.82%
6
TARSTARSUS PHARMACEUTICALS INC
1,188,624$97.3M4.81%-1,266,173
7
KNSAKINIKSA PHARMACEUTICALS INTL
2,259,889$93.2M4.60%-68,720
8
IMCRIMMUNOCORE HLDGS PLC
2,628,538$91.2M4.51%+323K
9
CMPXCOMPASS THERAPEUTICS INC
16,790,809$90.2M4.45%-21,154
10
KALVKALVISTA PHARMACEUTICALS INC
4,573,530$73.9M3.65%-468,268
11
RNAAVIDITY BIOSCIENCES INC
900,000$64.9M3.21%NEW
12
ANABANAPTYSBIO INC
1,332,087$64.6M3.19%-1,552
13
SYRESPYRE THERAPEUTICS INC
1,892,200$62.0M3.06%-1,307,800
14
VRDNVIRIDIAN THERAPEUTICS INC
1,792,626$55.8M2.76%-1,050,299
15
CAPRCAPRICOR THERAPEUTICS INC
1,700,000$49.1M2.42%NEW
16
BNTXBIONTECH SE
470,000$44.7M2.21%+200K
17
BSFAANI PHARMACEUTICALS INC
481,437$38.0M1.88%+164K
18
VRTXVERTEX PHARMACEUTICALS INC
80,000$36.3M1.79%
19
NUVBNUVATION BIO INC
3,857,457$34.6M1.71%-342,543
20
TVTXTRAVERE THERAPEUTICS INC
700,000$26.7M1.32%
21
VTYXVENTYX BIOSCIENCES INC
2,814,000$25.4M1.26%-286,000
22
NVDANVIDIA CORPORATION
127,788$23.8M1.18%-2,721
23
PGENPRECIGEN INC
5,617,500$23.5M1.16%-6,782,500
24
SPYSPDR S&P 500 ETF TR
30,000$20.5M1.01%NEW
25
MRNAMODERNA INC
692,820$20.4M1.01%+388K

Quarterly Changes

New Positions

Closed Positions

Increased Positions

NameSharesChange
HRTX6.3M+2.8M
MRNA693K+388K
IMCR2.6M+323K
BNTX470K+200K
CBIO872K+193K
BSFA481K+164K
PMVP4.9M+155K
PLRX6.1M+140K
TBPH351K+87K
IDYA450K+50K

Decreased Positions

NameSharesChange
NKTX1.5M-5574753
EOLS1.2M-4242607
CHRS2.7M-2372853
SYRE1.9M-1307800
TARS1.2M-1266173
VRDN1.8M-1050299
RCKT100K-750000
FATE1.2M-700000
TCRX46K-553869
KALV4.6M-468268

Sector Breakdown

Healthcare0.0% ($1.807051282231139e+293T)
Unknown0.0% ($3.8T)
Financial Services0.0% ($204.6B)
Technology0.0% ($23.8M)
Communication Services0.0% ($15.4M)
Real Estate0.0% ($2.0M)

Filing History

QuarterFiling DatePortfolio ValueHoldings
Q4 2025Feb 17, 2026$2.0B75
Q3 2025Nov 14, 2025$2.6T194
Q2 2025Aug 14, 2025$2.0T200
Q1 2025May 15, 2025$1.8T202
Q4 2024Feb 14, 2025$1.5T183
Q3 2024Nov 14, 2024$1399.9T154
Q2 2024Aug 14, 2024$981.9T128
Q1 2024May 15, 2024$960.4T99
Q4 2023Feb 14, 2024$1082.2T123
Q3 2023Nov 14, 2023$708.7T106
Q2 2023Aug 14, 2023$679.3T99
Q1 2023May 15, 2023$671.1T103
Q4 2022Feb 14, 2023$688.3T89
Q3 2022Nov 14, 2022$815.4B95
Q2 2022Aug 15, 2022$659.0B67
Q1 2022May 16, 2022$499.9B53
Q4 2021Feb 14, 2022$497.2B29
Q3 2021Nov 15, 2021$481.7B20
Q2 2021Aug 16, 2021$502.4B16
Q1 2021May 17, 2021$355.4B11
Q4 2020Feb 16, 2021$655.0B11
Q3 2020Nov 16, 2020$552.7B20
Q2 2020Aug 14, 2020$1.0T21
Q1 2020May 15, 2020$712.2B25
Q4 2019Feb 14, 2020$837.0B17
Q3 2019Nov 14, 2019$584.5B12
Q2 2019Aug 14, 2019$740.0B10
Q1 2019May 15, 2019$542.7B9
Q4 2018Feb 14, 2019$435.9B10
Q3 2018Nov 14, 2018$612.5B6
Q2 2018Aug 14, 2018$789.0B5
Q1 2018May 15, 2018$680.4B5
Q4 2017Feb 14, 2018$631.2B5
Q3 2017Nov 14, 2017$327.5B6
Q2 2017Aug 14, 2017$281.7B6
Q1 2017May 15, 2017$276.7B6
Q4 2016Feb 14, 2017$187.5B8
Q3 2016Nov 15, 2016$241.1B8
Q2 2016Aug 15, 2016$224.4B13
Q1 2016May 16, 2016$219.6B16

Fund Information

CIK0001232621
Most Recent FilingFeb 17, 2026
Number of Filings40

TANG CAPITAL MANAGEMENT LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $2.0B across 75 holdings. The largest position is AURINIA PHARMACEUTICALS INC (AUPH), representing 8.9% of the portfolio. Compared to the previous quarter, the fund opened 9 new positions and closed 128 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.